Previous Article | Next Article 
Journal of Virology, November 1998, p. 8913-8920, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Generation of Infectious Pancreatic Necrosis Virus
from Cloned cDNA
Kun
Yao and
Vikram N.
Vakharia*
Center for Agricultural Biotechnology,
University of Maryland Biotechnology Institute, and
Virginia-Maryland Regional College of Veterinary Medicine,
University of Maryland, College Park, Maryland 20742
Received 23 April 1998/Accepted 4 August 1998
 |
ABSTRACT |
We developed a reverse genetics system for infectious pancreatic
necrosis virus (IPNV), a prototype virus of the
Birnaviridae family, with the use of plus-stranded RNA
transcripts derived from cloned cDNA. Full-length cDNA clones of the
IPNV genome that contained the entire coding and noncoding regions of
RNA segments A and B were constructed. Segment A encodes a 106-kDa
precursor protein which is cleaved to yield mature VP2, nonstructural
protease, and VP3 proteins, whereas segment B encodes the RNA-dependent RNA polymerase VP1. Plus-sense RNA transcripts of both segments were
prepared by in vitro transcription of linearized plasmids with T7
RNA polymerase. Transfection of chinook salmon embryo (CHSE) cells with
combined transcripts of segments A and B generated infectious IPNV
particles 10 days posttransfection. Furthermore, a
transfectant virus containing a genetically tagged sequence was
generated to confirm the feasibility of this system. The presence and
specificity of the recovered virus were ascertained by
immunofluorescence staining of infected CHSE cells with rabbit
anti-IPNV serum and by nucleotide sequence analysis. In addition,
3'-terminal sequence analysis of RNA from the recovered
virus showed that extraneous nucleotides synthesized at the 3' end
during in vitro transcription were precisely trimmed or excluded during
replication, and hence these were not incorporated into the genome. An
attempt was made to determine if RNA-dependent RNA polymerase of IPNV
and infectious bursal disease virus (IBDV), another birnavirus, can
support virus rescue in heterologous combinations. Thus, CHSE cells
were transfected with transcripts derived from IPNV segment A and IBDV
segment B and Vero cells were transfected with transcripts derived from IBDV segment A and IPNV segment B. In either case, no infectious IPNV or IBDV particles were generated even after a third passage in
cell culture, suggesting that viral RNA-dependent RNA polymerase is
species specific. However, the reverse genetics system for IPNV
that we developed will greatly facilitate studies of viral replication
and pathogenesis and the design of a new generation of live attenuated
vaccines.
 |
INTRODUCTION |
Infectious pancreatic necrosis virus
(IPNV) is the causal agent of a highly contagious and destructive
disease of juvenile rainbow and brook trout as well as Atlantic salmon
(31). Highly virulent strains of IPNV can cause greater
than 90% mortality in hatchery stocks less than 4 months old.
Survivors of infection can remain lifelong asymptomatic carriers and
serve as reservoirs of infection (21). Therefore, IPNV is a
pathogen of major economic importance to the aquaculture industry.
There are two distinct serogroups of IPNV, designated serogroups A and
B. Serogroup A contains nine serotypes, whereas serogroup B contains a
single serotype (19).
IPNV is the prototype virus of the Birnaviridae family and
belongs to the Aquabirnavirus genus (10). The
IPNV genome consists of two segments of double-stranded RNA that are
surrounded by a single-shelled icosahedral capsid 60 nm in diameter
(7). The larger of the two genomic segments, segment A
(3,097 bp), encodes a 106-kDa precursor protein in a single large open
reading frame (ORF) which is cotranslationally cleaved by the viral
nonstructural (NS) protease to generate mature VP2 and VP3 structural
proteins (8, 12). Segment A also encodes a 17-kDa
arginine-rich NS protein from a small ORF, which precedes and partially
overlaps the major polyprotein ORF. Although this protein is not
present in the virion, it is detected in IPNV-infected cells
(20). Similarly, in infectious bursal disease virus (IBDV),
another member of the Birnaviridae family, segment A also
encodes a 17-kDa NS protein (from a small ORF) which is found in
IBDV-infected cells (22). Recently, it was
shown that this NS protein of IBDV is not required for viral
replication but plays an important role in pathogenesis (32). The genomic segment B (2,784 bp) encodes VP1, a 94-kDa minor internal protein, which is the virion-associated
RNA-dependent RNA polymerase (9, 13). In virions, VP1
is present as a free polypeptide, as well as a genome-linked
protein, VPg (2).
Although the nucleotide sequences for genome segments A and B of
various IPNV strains have been published, the precise 5'- and
3'-noncoding sequences of these strains have not been determined or confirmed (11, 13, 18). Unlike IBDV, there is extensive homology between the noncoding sequences of IPNV segments A and B. For example, 32 of 50 nucleotides at the 5'-noncoding region and 29 of 50 nucleotides at the 3'-noncoding region between the two segments
are conserved. These termini should contain sequences that are
important in the packaging and replication of the IPNV genome, as
demonstrated for other double-stranded RNA viruses, such as mammalian
reoviruses and rotaviruses (17, 25, 30, 34).
In recent years, a number of animal RNA viruses have been recovered
from cloned cDNA, such as poliovirus (a plus-stranded RNA virus),
influenza virus (a segmented negative-stranded RNA virus), and rabies
virus (a nonsegmented negative-stranded RNA virus) (14, 26,
29). Recently, we recovered IBDV (a double-stranded RNA virus
affecting poultry) from clone-derived transcripts of its genome
segments (24). However, to date, there is no report of a
recovered infectious virus from an aquatic species.
To study the function of RNA-dependent RNA polymerase of birnaviruses
and to develop a reverse genetics system for IPNV, we constructed
full-length cDNA clones of segments A and B of the West Buxton (WB)
strain. Complete nucleotide sequences of these cDNA clones were
determined, including those of the 5'- and 3'-noncoding regions. One of
the cDNA clones was modified by site-directed mutagenesis to create a
genetic tag in segment B. Synthetic plus-sense RNA transcripts of IPNV
segments A and B were produced by in vitro transcription reactions on
linearized plasmids with T7 RNA polymerase and used to transfect
chinook salmon embryo (CHSE) cells. Furthermore, transcripts derived
from IPNV segment A plus IBDV segment B and IBDV segment A plus IPNV
segment B were used to transfect CHSE and Vero cells, respectively. In
this report, we describe the recovery of IPNV from CHSE cells
transfected with homologous RNA transcripts of IPNV segments A and B
and evaluate the fate of IPNV or IBDV recovery in heterologous
combinations. Furthermore, we demonstrate the need for the capping of
the transcripts for virus rescue and the repair of the extraneous
nucleotides synthesized at the 3' end of these RNAs in the recovered
virus.
 |
MATERIALS AND METHODS |
Cells and viruses.
CHSE-214 cells (ATCC CRL-1681) were
maintained at room temperature in minimal essential medium containing
Hanks' salts and supplemented with 10% fetal bovine serum (FBS). Vero
cells were grown in M199 medium supplemented with 5% FBS at 37°C in
a humidified 5% CO2 incubator. These cells were used for
propagation of IPNV, transfection experiments, further propagation of
the recovered virus, and immunofluorescence studies, essentially as
described previously (24). The WB strain of IPNV (a
reference serogroup A1 strain) was kindly provided by Frank
M. Hetrick (Maryland Department of Agriculture, College Park, Md.) and
was purified as described previously with slight modifications
(4). Briefly, CHSE cells were infected with IPNV, and after
the cytopathic effect was visible, the cells were scraped into the
medium and the crude virus was clarified by centrifugation at
5,000 × g for 30 min at 4°C. The pellet was
resuspended in 10 ml of TNE buffer (0.1 M Tris-HCl [pH 7.4], 0.1 M
NaCl, 1 mM EDTA), mixed with 1 volume of Freon, and homogenized for 5 min. After centrifugation at 8,000 × g for 20 min at
4°C, the aqueous layer was aspirated and mixed with the supernatant
of the crude virus preparation. Polyethylene glycol (molecular weight,
20,000) was added to a final concentration of 10% (wt/vol), and the
mixture was incubated overnight at 4°C. The solution was centrifuged
at 8,000 × g for 30 min at 4°C to pellet the virus,
which was resuspended in 10 ml of TNE buffer. After Freon extraction,
the virus was pelleted at 100,000 × g for 1.5 h
at 4°C and resuspended in 0.5 ml of TNE buffer. The virus was layered
onto a cushion of 30% sucrose (wt/vol, in TNE buffer) and centrifuged
at 120,000 × g for 1 h at 4°C. Finally, the
virus pellet was resuspended in 100 µl of TNE buffer and stored at
20°C until use.
Determination of 5' and 3' termini of the IPNV genome.
Complete nucleotide sequences of 5'- and 3'-noncoding regions from both
genomic segments of IPNV were determined by two methods as described
for IBDV (23). Briefly, viral RNA was isolated from purified
virus by digestion with proteinase K (200-µg/ml final concentration)
for 6 h at 37°C in the presence of sodium dodecyl sulfate (1%)
followed by phenol-chloroform extraction and ethanol precipitation
(27). To determine the 3' termini of both strands of
segments A and B, the viral RNA was polyadenylated and reverse
transcribed with a poly(dT) primer
(5'-GCGGCCGCCCTTTTTTTTTTTTTTTT-3'), and resulting cDNAs were
amplified by PCR with either A-A3'F, A-A5'R, B-B3'F, or B-B5'R primer
(Table 1) (3). The reverse transcription (RT)-PCR products were separated by agarose gel electrophoresis, purified by using a QIAquick gel extraction kit (Qiagen, Inc.), and directly sequenced by the dideoxy chain termination method, using the segment-specific primers described above
(28). The 5' termini of segments A and B were determined by
the rapid amplification of cDNA ends method, using the 5' RACE system
(GIBCO/BRL) (16). Briefly, cDNA of segments A and B was
synthesized by RT reaction with virus-specific primers A-ApaR and
B-HindR (Table 1), respectively. The cDNA was purified by
chromatography on GlassMAX columns and tailed with oligo(dC) by using
terminal deoxynucleotidyltransferase. The tailed cDNA was amplified by
PCR with nested virus-specific primer A-A5'R or B-B5'R (Table 1) and
abridged anchor primer, in accordance with the manufacturer's
protocol. The PCR products were gel purified and directly sequenced by
using segment-specific primers as described above.
Construction of the full-length cDNA clones of IPNV.
The
cDNA clones containing the entire coding and noncoding regions of IPNV
RNA segments A and B were prepared by standard cloning procedures and
methods, as described previously for IBDV (24). Construction
of full-length cDNA clones of IBDV genome segments A and B of strain
D78 has been reported previously (24, 32). In addition, all
manipulations of DNAs were performed in accordance with standard
protocols (27). On the basis of published IPNV sequences of
the Jasper strain and the determined 5'- and 3'-terminal sequences of
the WB strain, several primer pairs were synthesized and employed in
RT-PCR amplifications (Table 1).
To generate cDNA clones of segment A of the WB strain, three primer
pairs (A-A5'NC plus A-ApaR, A-ApaF plus A-SalR, and A-SalF
plus
A-A3'NC) were used for RT-PCR amplification (Table
1). Using
genomic
RNA as a template, desired overlapping cDNA fragments
of segment A were
synthesized and amplified in accordance with
the supplier's protocol
(Perkin-Elmer). Amplified fragments were
cloned into the
EcoRI site of the pCR2.1 vector (Invitrogen Corp.)
to obtain
plasmids pCR#8, pCR#11, and pCR#23 (Fig.
1). The insert
DNA in all these plasmids
was sequenced by the dideoxy chain termination
method with an Applied
Biosystem automated DNA sequencer, and
the sequence data were analyzed
by using PC/GENE (Intelligenetics)
software. To construct a full-length
cDNA clone of segment A,
plasmids pCR#8, pCR#11, and pCR#23 were double
digested with restriction
enzyme pairs
Asp718 plus
ApaI,
ApaI plus
SalI, and
SalI plus
EcoRI
to release 670-, 1,520-, and
904-bp fragments, respectively. These
fragments were then cloned
between the
EcoRI and
Asp718 sites
of pUC19
vector to obtain plasmid pUC19WBA. This plasmid contains
a full-length
copy of segment A, which encodes all of the structural
and NS proteins
(Fig.
1). Similarly, to prepare cDNA clones of
segment B, three primer
pairs (B-B5'NC plus B-HindR, B-HindF plus
B-PstR, and B-PstF plus
B-Bgl3'NC) were used to generate overlapping
cDNA fragments of segment
B by RT-PCR amplification (Table
1).
Amplified fragments were cloned
into pCR2.1 vector as described
above to obtain plasmids pCR#4.1,
pCR#3, and pCR#29 (Fig.
2).
DNA from
these plasmids was sequenced and analyzed as described
above. Since
sequence analysis of plasmid pCR#3 revealed an internal
PstI site, it was necessary to make two
additional plasmids. To
construct these clones (pUC19B5'#2 and
pUC19B3'#5), plasmids pCR#4.1,
pCR#3, and pCR#29 were double digested
with enzyme pairs
EcoRI
plus
HindIII,
HindIII plus
Asp718 or
Asp718 plus
PstI, and
PstI
plus
BamHI. After these
digestions, respective fragments of 361,
626 or 293, and 1,503 bp were
released. The
EcoRI-
HindIII and
HindIII-
Asp718 fragments were first cloned
between the
EcoRI-
Asp718
sites of pUC19 vector to
obtain plasmid pUC19B5'#2.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Construction of the full-length cDNA clone of IPNV
segment A for the generation of plus-sense RNA transcript with T7 RNA
polymerase. The gene structure of IPNV segment A and its encoded
proteins are shown at the top. Overlapping cDNA segments of IPNV were
generated by RT-PCR and cloned into a pCR2.1 vector to obtain various
pCR clones, as indicated. These plasmids were digested with appropriate
restriction enzymes, and the resulting segments were cloned into a
pUC19 vector to obtain plasmid pUC19WBA. This plasmid contains a T7 RNA
polymerase promoter sequence at its 5' end. Restriction enzymes used
for the construction or linearization of the full-length clone are
indicated. Abbreviations: A, ApaI; E, EcoRI; K,
Asp718; S, SalI.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 2.
Construction of the full-length cDNA clone of IPNV
segment B for the synthesis of plus-sense RNA transcript with T7 RNA
polymerase. The genome segment B of IPNV encodes the RNA-dependent RNA
polymerase, VP1, which is shown at the top. Overlapping cDNA segments
of IPNV were cloned into the pCR2.1 vector to obtain various pCR
clones, as shown. These plasmids were digested with appropriate
restriction enzymes, and the resulting segments were cloned into the
pUC19 vector to obtain plasmids pUC19B5'#2 and pUC19B3'#5. Finally, a
full-length plasmid, pUC19WBB, which contains a T7 RNA polymerase
promoter sequence at its 5' end, was obtained from these two clones.
Restriction enzymes used for the construction of the above plasmids or
for linearization of the full-length clone are indicated.
Abbreviations: B, BamHI; E, EcoRI; H,
HindIII; K, Asp718; P, PstI.
|
|
The
Asp718-
PstI and
PstI-
BamHI fragments were then cloned between the
Asp718 and
BamHI sites of pUC19 vector to obtain
plasmid
pUC19B3'#5. Finally, to construct a full-length cDNA clone
of
segment B, plasmid pUC19B3'#5 was digested with
Asp718
and
BamHI,
and the resultant fragment was cloned into the
Asp718-
BamHI-digested
pUC19B5'#2 vector. A
representative clone of segment B was selected
and designated pUC19WBB,
which encodes VP1 protein (Fig.
2).
To introduce a sequence tag into IPNV segment B, plasmid pUC19WBBmut
was constructed by oligonucleotide-directed mutagenesis
with specific
primer pairs and PCR amplification of the parent
plasmid pUC19WBB. To
construct pUC19WBBmut, two primer pairs (B-SacF
plus B-Sma

R and
B-Sma

F plus B-BstR [Table
1]) were synthesized
and used to amplify
the DNA fragments of 568 and 407 bp, respectively.
These fragments were
combined and subsequently amplified by PCR
with the flanking primers
(B-SacF plus B-BstR) to produce a 954-bp
fragment. This fragment was
digested with
SacII and
BstEII enzymes,
and the
resulting fragment (798 bp) was cloned back into the
SacII-
BstEII-cleaved
parent plasmid pUC19WBB. As
a result of this mutation, the unique
internal
SmaI site in
this plasmid was deleted. Another plasmid,
pUC19WBB-Sma, was
constructed which upon linearization with
SmaI
enzyme and
transcription reaction would yield RNA transcript with
precise 3'-end
sequences as the genomic RNA. To construct this
plasmid, primer pairs
(B-BstF plus B-Sma3'NC [Table
1]) were
synthesized and used to
amplify by PCR a 723-bp fragment from
pUC19WBmut template. The
amplified fragment was digested with
BstEII and
BglII enzymes, and the resulting fragment (584 bp)
was
cloned back into the same sites of this plasmid. Finally,
a
representative clone of segment B which lacked an internal
SmaI
site was selected and designated pUC19WBB-Sma. The
integrity of
the full-length constructs, pUC19WBA, pUC19WBB, and
pUC19WBB-Sma,
was tested by coupled in vitro transcription and
translation in
a reticulocyte lysate system with T7 RNA polymerase
(Promega Corp.).
Transcription and transfection of synthetic RNAs.
Plasmid
pUC19WBA and plasmids pUC19WBB and pUC19WBB-Sma were digested with
SmaI and with both BglII and SmaI,
respectively (Fig. 1 and 2), and used as templates for in vitro
transcription with T7 RNA polymerase (Promega). Similarly,
plasmids pUC19FLAD78 and pUCD78B were linearized with
BsrGI and PstI enzymes, respectively, as
described earlier (24, 32). The linearized DNA templates (
3 µg) recovered after phenol-chloroform extraction and ethanol precipitation were added separately to a transcription reaction mixture
(50 µl) containing 40 mM Tris-HCl (pH 7.9), 10 mM NaCl, 6 mM
MgCl2, 2 mM spermidine, 0.5 mM (each) ATP, CTP and UTP, 0.1 mM GTP, 0.25 mM cap analogue [m7G(5')ppp(5')G], 120 U of RNasin, and
150 U of T7 RNA polymerase (Promega), and the mixture was incubated at 37°C for 1 h. Under these conditions, up to 70% of the transcripts were capped and purified by phenol-chloroform extraction and ethanol precipitation. As controls, the transcription products were treated with either DNase or RNase (Promega) before the
purification step.
Transfection assays were carried out in accordance with the protocol
supplied by the manufacturer, using Lipofectin reagent
(Life
Technologies). Vero cells were transfected as described
in detail
previously (
24). To transfect CHSE cells, the monolayers
were grown to 80% confluence in 60-mm-diameter dishes and washed
once
with phosphate-buffered saline (PBS). Three milliliters of
OPTI-MEM I
(Life Technologies) was added to the monolayers, and
the cells were
incubated at room temperature for 1 h. Simultaneously,
0.15 ml of
OPTI-MEM I was incubated with 12.5 µg of Lipofectin
reagent for 45 min in a polystyrene tube at room temperature.
Equimolar amounts of RNA
transcripts of segments A and B (

8 µg
each) were resuspended in
0.15 ml of diethyl pyrocarbonate-treated
water, added to the
OPTI-MEM-Lipofectin mixture, mixed gently,
and incubated on ice for 5 min. After removing the OPTI-MEM from
the monolayers in 60-mm-diameter
dishes and replacing it with
a fresh 1.5 ml of OPTI-MEM, the nucleic
acid-containing mixture
was added dropwise to CHSE cells and swirled
gently. After 3 h
of incubation at room temperature, the mixture
was replaced with
minimal essential medium containing Hanks' salts and
10% FBS (without
rinsing the cells). The cultures were incubated at
room temperature
for desired time intervals, and the cell
supernatant was harvested
and passaged (referred to as passage 2) onto
fresh CHSE monolayers.
These passage 2 cultures were incubated at
room temperature for
4 to 6 days, and the virus present in the cell
supernatant was
harvested and passaged once more in CHSE cultures
(referred to
as passage 3). Cells transfected with combined plus-sense
transcripts
derived from plasmids pUC19WBA and pUC19WBB or pUC19WBA and
pUC19WBB-Sma
gave rise to virus progeny which were designated
recombinant WB
(rWB) and rWB-Sma, respectively.
Characterization of recovered IPNV.
To determine the
specificity of the recovered viruses, CHSE cells were infected with the
supernatants of rWB or rWB-Sma IPNV and the infected cells were
analyzed by immunofluorescence assay (IFA) with rabbit anti-IPNV
polyclonal serum. The anti-IPNV serum, prepared against the Jasper
strain of serogroup A, was kindly provided by Ana Baya
(Virginia-Maryland Regional College of Veterinary Medicine, College
Park, Md.). CHSE cells, grown on coverslips to 80% confluence, were
infected with the supernatants of rWB or rWB-Sma IPNV and incubated at
room temperature for an appropriate time interval. The cells were then
washed with PBS, fixed with ice-cold methanol-acetone (1:1), and
treated with rabbit anti-IPNV serum. After being washed with PBS, the
cells were treated with fluorescein-labeled goat anti-rabbit antibody
(Kirkegaard & Perry Laboratories) and examined by fluorescence
microscopy.
To identify the tagged sequence in recovered viruses, total nucleic
acids of uninfected and IPNV-infected CHSE cells were
isolated and
analyzed by RT-PCR as described above. Segment B-specific
primer
B-BstR, binding to nucleotide positions 2285 to 2305 (Table
1), was
used for RT of genomic RNA. Following RT, the reaction
products were
amplified by PCR with an upstream segment B-specific
primer, B-SacF
(binding to nucleotide positions 1351 to 1371 [Table
1]). The
resulting PCR fragments (954 bp) were gel purified and
either sequenced
as described before or digested with
SmaI enzyme
to
determine the tag sequence.
To determine the 3'-terminal sequence of segment B in recovered
viruses, total RNA of rWB- or rWB-Sma-infected cells was
polyadenylated,
reverse transcribed with a poly(dT) primer, and
amplified by PCR
with the B-B3'F primer, as described above. The RT-PCR
products
(329 bp) were gel purified and directly sequenced with the
B-B3'F
primer (Table
1) and a Dye Deoxy Terminator Cycle Sequencing
kit
(Applied Biosystems).
Plaque assay.
Monolayers of CHSE cells, grown in six-well
plates (2 × 106 cells/well), were infected with
serially diluted supernatants derived from transfected CHSE cells in
duplicate (0.5 ml/well). One hour postinfection, the cells were rinsed
with serum-free medium and overlaid with minimal essential medium
containing Hanks' salts, 5% FBS, and 0.75% methylcellulose. The
cells were incubated at 16°C for 7 to 10 days, fixed, and stained
with a solution containing 25% formalin, 10% ethanol, 5% acetic
acid, and 1% crystal violet for 5 min at room temperature. After
rinsing the cells with distilled water, the plaques were counted, and
the titers of the virus were calculated as plaque-forming units per
milliliter of supernatant.
Nucleotide sequence accession number.
The complete
nucleotide sequences of the IPNV genome segments A and B of the WB
strain have been deposited in GenBank under accession no. AF078668 and
AF078669, respectively.
 |
RESULTS |
Sequence analysis of IPNV genome.
We determined the
complete nucleotide sequences of IPNV genome segments
A and B, including the precise 5'- and 3'-terminal sequences. Segment A is 3,097 bp long and contains two
overlapping ORFs. The major ORF encodes the structural VP2 and VP3
proteins and the NS protease, whereas the minor ORF codes for the NS
protein (Fig. 1). Segment B is 2,783 bp long and encodes VP1, which is the RNA-dependent RNA polymerase (Fig. 2). Comparison of the 5'- and
3'-terminal sequences of segments A and B of WB strain with those of
the Jasper strain (GenBank accession no. M18049 and M58756) showed
some minor differences. For example, in segment A, a deletion of a T
residue at nucleotide position 106 and an addition of a C residue
at position 3097 were detected, whereas in segment B, a deletion
of a C residue was found at position 2646 (Fig.
3). Comparison of the nucleotide and
deduced amino acid sequences of WB strain segments A and B with those
of the Jasper strain showed 91.64 and 90.37% identity at the
nucleotide level and 97.22 and 97.16% identity at the amino acid
level, respectively. This indicates that these two North American
strains of IPNV are closely related. However, comparison of the
nucleotide and deduced amino acid sequences of IPNV WB strain segments
A and B with those of IBDV strain D78 showed 56.22 and 57.6% identity
at the nucleotide level and 32.1 and 45.2% identity at the amino acid
level, respectively.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 3.
Nucleotide sequence comparison of the 5'- and
3'-noncoding regions of segments A (A) and B (B) of IPNV strains Jasper
(JAS) and West Buxton (WB). The start and stop codons of segments A and
B major ORFs of both strains are in boldface type. Nucleotide
differences between the two strains are marked by ×, and nucleotide
identity is indicated by lines connecting identical residues.
Nucleotide deletions in the WB strain are marked by *, and an
additional C residue at the 3' end of WB segment A is indicated by a +.
Invert terminal repeats in segments A and B of both strains are shaded
and italicized.
|
|
Construction of full-length cDNA clones.
To develop a reverse
genetics system for IPNV, we constructed full-length cDNA clones of
segments A and B of IPNV strain WB. Plasmid pUC19WBA, upon digestion
with SmaI and transcription in vitro by T7 RNA polymerase,
yielded RNA with precise 5' and 3' ends, and it encoded all of the
structural and NS proteins (Fig. 1). However, after linearization with
BglII and transcription, plasmid pUC19WBB yielded RNA with
the correct 5' end but with an additional five nucleotides at the 3'
end, and it encoded VP1 protein (Fig. 2). We also constructed plasmid
pUC19WBB-Sma with a genetic tag (the elimination of an internal
SmaI site) to identify the virus as being of recombinant
origin. Linearization of this plasmid with SmaI and
transcription in vitro yielded RNA with precise 5' and 3' ends. Coupled
transcription and translation of the above plasmids in a rabbit
reticulocyte system yielded protein products which comigrated with the
marker IPNV proteins after fractionation on a sodium dodecyl
sulfate-12.5% polyacrylamide gel and autoradiography (data not
shown).
Transfection and recovery of IPNV.
Plus-sense
transcripts of IPNV segments A and B were synthesized separately
in vitro with T7 RNA polymerase with linearized plasmids
pUC19WBA, pUC19WBB, and pUC19WBB-Sma as templates.
Equimolar amounts of RNA transcript(s) of segments A and B
(
8 µg each) were then used to transfect CHSE cells. The efficiency
of transfection was monitored by the
-gal staining assay, which
measures the combined uptake of
-galactosidase and RNA-dependent RNA
polymerase transcripts in transfected cells (33). Under
these conditions, about 1.5% of the transfected CHSE cells would
contain transcripts of both segments A and B. The cultures were
incubated at room temperature for desired time intervals, and the cell
supernatants were harvested and passaged (referred to as passage 2)
onto fresh CHSE monolayers. Our results indicate that the transcripts
derived from plasmids pUC19WBA and pUC19WBB were able to generate
infectious virus (rWB) 12 days posttransfection, as evidenced by
the appearance of cytopathic effect (CPE). Similarly, transcripts
derived from plasmids pUC19WBA and pUC19WBB-Sma, either untreated or
treated with DNase, gave rise to infectious virus (rWB-Sma) 10 days
posttransfection. No CPE was detected when CHSE cells were transfected
with either RNase-treated transcripts or uncapped RNAs of plasmids
pUC19WBA and pUC19WBB-Sma, individual RNA of each plasmid, or
Lipofectin reagent. These results indicate that the capped and
plus-sense RNA transcripts of segments A and B are required for the
generation of IPNV, which is in agreement with the previous findings on
IBDV reported from our laboratory (24).
To determine the time point for the recovery of infectious virus, CHSE
cells were transfected with combined RNA transcripts
of segments A and
B. At 2, 4, 6, 8, and 10 days posttransfection,
the cells were examined
for the presence of viral antigens by
IFA, and the cell supernatants
were analyzed for the presence
of transfectant virus by plaque assays,
as shown in Table
2.
Our results indicate
that as early as 4 days posttransfection,
infectious virus with a titer
of 1.2 × 10
1 PFU/ml (which gradually increased) was
produced. After several
cycles of virus multiplication, the titer of
the virus was high
enough to cause overt CPE (about 80%) at day 10 posttransfection.
After the third passage, the titer of these recovered
viruses
was comparable to that of the parental WB strain (

1 × 10
8 PFU/ml).
To determine the specificities of the recovered viruses, CHSE cells
were infected with the supernatants derived from the third
passage of
either rWB or rWB-Sma viruses. At various time intervals,
the cells
were harvested and analyzed by IFA with anti-IPNV polyclonal
serum.
Figure
4 shows the results of
immunofluorescence staining
of IPNV-infected cells. CHSE cells infected
with recovered IPNV
gave a positive green immunofluorescence signal,
indicating the
expression of virus-specific proteins (Fig.
4b through
e). However,
no fluorescence was detected in the mock-infected cells at
24
h and 72 h (Fig.
4a and f).

View larger version (79K):
[in this window]
[in a new window]
|
FIG. 4.
Immunofluorescence staining of IPNV-infected cells for
the detection of virus-specific proteins. CHSE cells were infected with
the supernatant of rWB-Sma virus stock (after the third passage) and
harvested at different time intervals. Cells were fixed at 24 h
(b), 36 h (c), 48 h (d), and 72 h (e) postinfection and
were analyzed by IFA with rabbit anti-IPNV polyclonal serum. Uninfected
CHSE cells at 24 h (a) and 72 h (f) were used as negative
controls. Magnification, ×184.
|
|
Identification of tagged sequence.
To demonstrate the utility
of the reverse genetics system, two recombinant IPNVs were generated.
To introduce a tagged sequence in segment B, plasmid
pUC19WBB-Sma, in which a unique internal SmaI site in
the VP1 gene was eliminated by site-directed mutagenesis, was
constructed. Synthetic transcripts of this plasmid or of pUC19WBB and pUC19WBA were then used to transfect CHSE cells. To verify the presence or absence of mutation in recovered rWB and rWB-Sma viruses, genomic RNA was isolated and analyzed by RT-PCR with a primer
pair specific for segment B. Figure 5
shows the analysis of RT-PCR products from recovered viruses before and
after SmaI digestion. A 954-bp fragment was obtained
from both rWB and rWB-Sma viruses (lanes 5 and 6), but not from the
CHSE cells (lane 4). Moreover, no PCR product was detected in
mock-infected or IPNV-infected cells if the RT was omitted from the
reaction before PCR (lanes 1 to 3). This indicates that the PCR product
was derived from RNA and not from contaminating DNA. SmaI
digestion of the PCR product of rWB virus yielded the expected
fragments of 403 and 551 bp. However, the PCR product of the mutant
virus (lane 8), rWB-Sma, was not digested by SmaI (lane 7).
Furthermore, sequence analysis of this PCR product confirmed the
expected nucleotide mutation (deletion of a SmaI site) in
the VP1 gene (data not shown). These results show that the tagged
sequence is present in the genomic RNA of the recovered virus.

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 5.
Analysis of the RT-PCR products to identify the tagged
sequence in segment B of recovered viruses. Genomic RNA isolated from
recovered viruses was amplified by RT-PCR with segment B-specific
primers B-BstR (binding to nucleotide positions 2285 to 2305) and
B-SacF (binding to positions 1351 to 1371), and the products were
analyzed on 1% agarose. A 954-bp fragment was obtained from rWB
and rWB-Sma viruses (lanes 5 and 6), but not from the CHSE cells (lane
4) or the control(s) in which reverse transcriptase was omitted from
the reaction (lanes 1 to 3). Gel-purified RT-PCR products were digested
with SmaI as indicated (lanes 7 and 8). Only the DNA derived
from parental virus (rWB) was digested, yielding fragments of 403 and
551 bp (lane 8), whereas the DNA of the rWB-Sma virus remained
undigested because of an elimination of this SmaI site by
site-directed mutagenesis (lane 7). A 123-bp ladder (left lane M) and
lambda DNA digested with HindIII-EcoRI (right
lane M) were used as markers.
|
|
Fate of extraneous nucleotides synthesized at 3' end of RNA
transcript.
Since plus-sense RNA transcript derived from plasmid
pUC19WBB contained five additional nucleotides at its 3' end after
linearization with BglII (Fig. 2), it was of interest to
determine whether the double-stranded RNA present in the recovered
virus also retained vector-derived nucleotides. Therefore, RNA from
recovered viruses was polyadenylated, reverse transcribed with a
poly(dT) primer, and amplified by PCR with segment B-specific primer,
and the product was directly sequenced with the latter primer. Our
results show that the extraneous nucleotides present in the
synthesized RNA were not incorporated in the genome segment B of the
recovered virus. This suggests that vector-derived nucleotides were
precisely trimmed or excluded before being packaged into the virion.
RNA-dependent RNA polymerase of birnaviruses does not
function in heterologous systems.
To determine if
RNA-dependent RNA polymerase of IPNV and IBDV can support
virus rescue in heterologous combinations, CHSE cells were
transfected with transcripts derived from IPNV segment A plus
IBDV segment B, and Vero cells were transfected with
transcripts derived from IBDV segment A plus IPNV segment B. In either
case, no infectious IPNV or IBDV particles were generated even
after the third passage in cell culture, indicating that viral
RNA-dependent RNA polymerase is species specific.
 |
DISCUSSION |
In this communication, we describe the generation of IPNV from
fish cells with the use of plus-stranded RNA transcripts derived from
cloned cDNA of genomic segments A and B. This is the first report of an
infectious RNA virus recovered from an aquatic species. The
prerequisite for the construction of infectious clones of IPNV was the
identification of the precise 5'- and 3'-terminal sequences, which are
crucial for replication of viral RNA (25, 30). We determined
the 5'- and 3'-noncoding sequences from both genomic segments of IPNV
by poly(A) tailing and 5' RACE methods. We found an additional C
residue at the 3' end of segment A of the WB strain, but the
remaining terminal sequence was homologous to the published sequence of
Jasper strain (11, 13). Based on these results,
full-length cDNA clones of WB-IPNV genomic segments A and B were
constructed. In these clones, a T7 RNA polymerase promoter sequence was
also placed at its 5' end to generate synthetic transcripts in
vitro with T7 RNA polymerase. Upon transfection of CHSE
cells with combined plus-sense RNA transcripts of segments A and
B, recombinant IPNV (rWB) and recombinant IPNV bearing a tagged
sequence (rWB-Sma) were efficiently recovered without the use
of a helper virus or other viral proteins. The presence of the
tagged sequence was verified by sequence analysis and restriction enzyme digestion of the RT-PCR products. These results unequivocally prove that the recovered virus was derived from the synthetic transcripts and that it was of recombinant origin.
The reverse genetics system for IPNV described here is very similar to
the one developed for another birnavirus, IBDV, with which we
demonstrated that synthetic transcripts of the IBDV genome are
infectious and can give rise to a replicating virus (24). However, the significance of the cap analogue in generating infectious virus and the fate of extraneous nucleotides synthesized at the 3' end
during transcription were not determined. In the present study, we
demonstrate that the "capping" of RNA transcripts was necessary to
generate infectious virus, suggesting that the cap structure is
essential for translation of synthetic mRNA. No significant difference
in the stability of the synthesized RNAs, in the presence or absence of
the cap, was observed in vitro. Moreover, 3'-terminal sequence analysis
of RNA from recovered viruses shows that the extraneous nucleotides
present in the synthetic RNA of segment B were not incorporated into
the genome and were probably trimmed or excluded by the expressed
RNA-dependent RNA polymerase during replication. Similar effects have
been observed in several RNA viruses that have been recovered,
including an unencapsidated hypovirus (1, 5). Nevertheless,
this did not prevent the replication of the viral double-stranded RNA.
It appears that recovery of this virus (rWB) was somewhat less
efficient than that of the rWB-Sma virus, which was recovered with
transcripts containing bona fide 5' and 3' ends. We did not examine
whether extraneous nucleotides of segment A would also be excluded if plasmid pUC19WBA were linearized with BglII enzyme,
but we would predict a similar fate. This is because when we analyzed
the 3'-terminal sequence of RNA from recovered IBDV, all
four vector-derived nucleotides were absent in segment A of the IBDV
genome (33). However, the mechanism by which the omission of
these nucleotides takes place is not known. One can speculate that
since both segments of IPNV contain inverted terminal repeats (Fig. 3),
these form a panhandle structure, similar to that reported for
influenza virus, which the RNA polymerase could recognize to initiate
transcription at a specific location (15). In addition, our
results indicate that RNA-dependent RNA polymerase of birnavirus is
species specific, since it does not support virus rescue in
heterologous systems.
From our study, it is evident that transfected RNAs from both segments
had to be translated in the host cells to produce functional proteins VP2, NS protease, VP3, and VP1 (RNA-dependent RNA
polymerase). Since only the plus-strand RNAs of both segments
were introduced into the cell, the minus-strand RNAs must have
been synthesized from the plus-strand RNA templates by VP1 or
RNA-dependent RNA polymerase to form double-stranded RNA. These results
accord with the general features of rotavirus replication, where the
plus-strand RNAs serve as a template for the synthesis of negative
strands, which then yield double-stranded RNA (6, 25, 30).
However, Dobos reported that in vitro transcription of IPNV is primed
by genome-linked VP1 and that only the plus-strand RNAs, which remain base paired to their respective negative-strand templates, are synthesized by RNA-dependent RNA polymerase (9). These
results indicate an asymmetric and semiconservative strand-displacement mechanism of replication, a possibility that should not be excluded.
The development of a reverse genetics system for IPNV presents new
opportunities for studies directed at viral replication, persistence,
and pathogenesis. In addition, it will greatly facilitate the
construction of novel, live attenuated, marked vaccines for IPNV that
are nonpathogenic to fish.
 |
ACKNOWLEDGMENTS |
We thank Donald L. Nuss for reviewing the manuscript and Gerard
H. Edwards for technical assistance.
This work was supported in part by a Maryland Agricultural Experiment
Station and Maryland Industrial Partnerships grant (MIPS no. 1701.29)
to V.N.V.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Center for
Agricultural Biotechnology, 6126 Plant Sciences Building, University of Maryland, College Park, Maryland 20742. Phone: (301) 405-4777. Fax:
(301) 314-9075. E-mail: vakharia{at}umbi.umd.edu.
 |
REFERENCES |
| 1.
|
Boyer, J. C., and A. L. Haenni.
1994.
Infectious transcripts and cDNA clones of RNA viruses.
Virology
198:415-426[Medline].
|
| 2.
|
Calvert, J. G.,
E. Nagy,
M. Soler, and P. Dobos.
1991.
Characterization of the VPg-dsRNA linkage of infectious pancreatic necrosis virus.
J. Gen. Virol.
72:2563-2567[Abstract/Free Full Text].
|
| 3.
|
Cashdollar, L. W.,
J. Esparza,
J. R. Hudson,
R. Chmelo,
P. W. K. Lee, and W. K. Joklik.
1982.
Cloning of double-stranded RNA genes of reovirus: sequences of the cloned S2 gene.
Proc. Natl. Acad. Sci. USA
79:7644-7648[Abstract/Free Full Text].
|
| 4.
|
Chang, N.,
R. D. MacDonald, and T. Yamamoto.
1978.
Purification of infectious pancreatic necrosis (IPN) virus and comparison of peptide composition of different isolates.
Can. J. Microbiol.
24:19-27[Medline].
|
| 5.
|
Chen, B.,
M. G. Craven,
G. H. Choi, and D. L. Nuss.
1994.
cDNA-derived hypovirus RNA in transformed chestnut blight fungus is spliced and trimmed of vector nucleotides.
Virology
202:441-448[Medline].
|
| 6.
|
Chen, D.,
C. Q.-Y. Zeng,
M. J. Wentz,
M. Gorziglia,
M. K. Estes, and R. F. Ramig.
1994.
Template-dependent, in vitro replication of rotavirus RNA.
J. Virol.
68:7030-7039[Abstract/Free Full Text].
|
| 7.
|
Dobos, P.
1976.
Size and structure of the genome of infectious pancreatic necrosis virus.
Nucleic Acids Res.
3:1903-1919.
|
| 8.
|
Dobos, P.
1977.
Virus-specific protein synthesis in cells infected by infectious pancreatic necrosis virus.
J. Virol.
21:242-258[Abstract/Free Full Text].
|
| 9.
|
Dobos, P.
1995.
Protein-primed RNA synthesis in vitro by the virion associated RNA polymerase of infectious pancreatic necrosis virus.
Virology
208:19-25[Medline].
|
| 10.
|
Dobos, P.
1995.
The molecular biology of infectious pancreatic necrosis virus (IPNV).
Annu. Rev. Fish Dis.
5:24-54.
|
| 11.
|
Duncan, R., and P. Dobos.
1986.
The nucleotide sequence of infectious pancreas necrosis virus (IPNV) dsRNA segment A reveals one large ORF encoding a precursor polyprotein.
Nucleic Acids Res.
14:5934[Free Full Text].
|
| 12.
|
Duncan, R.,
E. Nagy,
P. J. Krell, and P. Dobos.
1987.
Synthesis of the infectious pancreatic necrosis virus polyprotein, detection of a virus-encoded protease, and fine structure mapping of genome segment A coding regions.
J. Virol.
61:3655-3664[Abstract/Free Full Text].
|
| 13.
|
Duncan, R.,
C. L. Mason,
E. Nagy,
J. A. Leong, and P. Dobos.
1991.
Sequence analysis of infectious pancreatic necrosis virus genome segment B and its encoded VP1 protein: a putative RNA-dependent RNA polymerase lacking the Gly-Asp-Asp motif.
Virology
181:541-552[Medline].
|
| 14.
|
Enami, M.,
W. Luytjes,
M. Krystal, and P. Palese.
1990.
Introduction of site-specific mutations into the genome of influenza virus.
Proc. Natl. Acad. Sci. USA
87:3802-3807[Abstract/Free Full Text].
|
| 15.
|
Fodor, E.,
D. C. Pritlove, and G. G. Brownlee.
1994.
The influenza virus panhandle is involved in the initiation of transcription.
J. Virol.
68:4092-4096[Abstract/Free Full Text].
|
| 16.
|
Frohman, M. A.,
M. K. Dush, and G. R. Martin.
1988.
Rapid production of full-length cDNA rare transcripts: amplification using a single gene-specific oligonucleotide primer.
Proc. Natl. Acad. Sci. USA
85:8998-9002[Abstract/Free Full Text].
|
| 17.
|
Gorziglia, M. I., and P. L. Collins.
1992.
Intracellular amplification and expression of a synthetic analog of rotavirus genomic RNA bearing a foreign marker gene: mapping cis-acting nucleotides in the 3'-noncoding region.
Proc. Natl. Acad. Sci. USA
89:5784-5788[Abstract/Free Full Text].
|
| 18.
|
Hävarstein, L. S.,
K. H. Kalland,
K. E. Christie, and C. Endresen.
1990.
Sequence of the large double-stranded RNA segment of the N1 strain of infectious pancreatic necrosis virus: a comparison with other Birnaviridae.
J. Gen. Virol.
71:299-308[Abstract/Free Full Text].
|
| 19.
|
Hill, B. J., and K. Way.
1995.
Serological classification of infectious pancreatic necrosis (IPN) virus and other aquatic birnaviruses.
Annu. Rev. Fish Dis.
5:55-77.
|
| 20.
|
Magyar, G., and P. Dobos.
1994.
Evidence for the detection of the infectious pancreatic necrosis virus polyprotein and the 17-kDa polypeptide in infected cells and of the NS protease in purified virus.
Virology
204:580-589[Medline].
|
| 21.
|
McAllister, P. E.,
W. J. Owens, and T. M. Ruppenthal.
1987.
Detection of infectious pancreatic necrosis virus in pelleted cell and particulate components from ovarian fluid of brook trout (Salvilimus fontindis).
Dis. Aquat. Org.
2:235-237.
|
| 22.
|
Mundt, E.,
J. Beyer, and H. Müller.
1995.
Identification of a novel viral protein in infectious bursal disease virus-infected cells.
J. Gen. Virol.
76:437-443[Abstract/Free Full Text].
|
| 23.
|
Mundt, E., and H. Müller.
1995.
Complete nucleotide sequences of 5'- and 3'-noncoding regions of both genome segments of different strains of infectious bursal disease virus.
Virology
209:10-18[Medline].
|
| 24.
|
Mundt, E., and V. N. Vakharia.
1996.
Synthetic transcripts of double-stranded birnavirus genome are infectious.
Proc. Natl. Acad. Sci. USA
93:11131-11136[Abstract/Free Full Text].
|
| 25.
|
Patton, J. T.,
M. Wentz,
J. Xiaobo, and R. F. Ramig.
1996.
cis-acting signals that promote genome replication in rotavirus mRNA.
J. Virol.
70:3961-3971[Abstract].
|
| 26.
|
Racaniello, V. R., and D. Baltimore.
1981.
Cloned poliovirus complementary DNA is infectious in mammalian cells.
Science
214:916-919[Abstract/Free Full Text].
|
| 27.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 28.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 29.
|
Schnell, M. J.,
T. Mebatsion, and K. K. Conzelmann.
1994.
Infectious rabies viruses from cloned cDNA.
EMBO J.
13:4195-4205[Medline].
|
| 30.
|
Wentz, M. J.,
J. T. Patton, and R. F. Ramig.
1996.
The 3'-terminal consensus sequence of rotavirus mRNA is the minimal promoter of negative-strand RNA synthesis.
J. Virol.
70:7833-7841[Abstract].
|
| 31.
|
Wolf, K.
1988.
Fish viruses and fish viral diseases.
Canstock Publishing Associates, Cornell University Press, Ithaca, N.Y.
|
| 32.
|
Yao, K.,
M. A. Goodwin, and V. N. Vakharia.
1998.
Generation of a mutant infectious bursal disease virus that does not cause bursal lesions.
J. Virol.
72:2647-2654[Abstract/Free Full Text].
|
| 33.
| Yao, K., and V. N. Vakharia. Unpublished data.
|
| 34.
|
Zou, S., and E. G. Brown.
1992.
Identification of sequence elements containing signals for replication and encapsidation of the reovirus M1 genome segment.
Virology
186:377-388[Medline].
|
Journal of Virology, November 1998, p. 8913-8920, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hon, C.-C., Lam, T. T.-Y., Yip, C.-W., Wong, R. T.-Y., Shi, M., Jiang, J., Zeng, F., Leung, F. C.-C.
(2008). Phylogenetic evidence for homologous recombination within the family Birnaviridae. J. Gen. Virol.
89: 3156-3164
[Abstract]
[Full Text]
-
Pedersen, T., Skjesol, A., Jorgensen, J. B.
(2007). VP3, a Structural Protein of Infectious Pancreatic Necrosis Virus, Interacts with RNA-Dependent RNA Polymerase VP1 and with Double-Stranded RNA. J. Virol.
81: 6652-6663
[Abstract]
[Full Text]
-
Song, H., Santi, N., Evensen, O., Vakharia, V. N.
(2005). Molecular Determinants of Infectious Pancreatic Necrosis Virus Virulence and Cell Culture Adaptation. J. Virol.
79: 10289-10299
[Abstract]
[Full Text]
-
Santi, N., Song, H., Vakharia, V. N., Evensen, O.
(2005). Infectious Pancreatic Necrosis Virus VP5 Is Dispensable for Virulence and Persistence. J. Virol.
79: 9206-9216
[Abstract]
[Full Text]
-
Boot, H. J., Pritz-Verschuren, S. B. E.
(2004). Modifications of the 3'-UTR stem-loop of infectious bursal disease virus are allowed without influencing replication or virulence. Nucleic Acids Res
32: 211-222
[Abstract]
[Full Text]
-
Da Costa, B., Soignier, S., Chevalier, C., Henry, C., Thory, C., Huet, J.-C., Delmas, B.
(2002). Blotched Snakehead Virus Is a New Aquatic Birnavirus That Is Slightly More Related to Avibirnavirus Than to Aquabirnavirus. J. Virol.
77: 719-725
[Abstract]
[Full Text]
-
Benjeddou, M., Leat, N., Allsopp, M., Davison, S.
(2002). Development of infectious transcripts and genome manipulation of Black queen-cell virus of honey bees. J. Gen. Virol.
83: 3139-3146
[Abstract]
[Full Text]
-
Tacken, M. G. J., Peeters, B. P. H., Thomas, A. A. M., Rottier, P. J. M., Boot, H. J.
(2002). Infectious Bursal Disease Virus Capsid Protein VP3 Interacts both with VP1, the RNA-Dependent RNA Polymerase, and with Viral Double-Stranded RNA. J. Virol.
76: 11301-11311
[Abstract]
[Full Text]
-
Iwamoto, T., Mise, K., Mori, K.-i., Arimoto, M., Nakai, T., Okuno, T.
(2001). Establishment of an infectious RNA transcription system for Striped jack nervous necrosis virus, the type species of the betanodaviruses. J. Gen. Virol.
82: 2653-2662
[Abstract]
[Full Text]
-
Weber, S., Fichtner, D., Mettenleiter, T. C., Mundt, E.
(2001). Expression of VP5 of infectious pancreatic necrosis virus strain VR299 is initiated at the second in-frame start codon. J. Gen. Virol.
82: 805-812
[Abstract]
[Full Text]
-
Schröder, A., van Loon, A. A. W. M., Goovaerts, D., Mundt, E.
(2000). Chimeras in noncoding regions between serotypes I and II of segment A of infectious bursal disease virus are viable and show pathogenic phenotype in chickens. J. Gen. Virol.
81: 533-540
[Abstract]
[Full Text]